Africa: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Africa

The African prophylactic medicaments containing insulin market declined slightly to $X in 2022, approximately equating the previous year. The market value increased at an average annual rate of +3.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market reached the maximum level at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Africa

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. The total output value increased at an average annual rate of +2.6% from 2012 to 2022; however, the trend pattern remained relatively stable, with only minor fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2017 when the production volume increased by 13% against the previous year. Over the period under review, production attained the maximum level in 2022 and is likely to continue growth in the near future.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Africa

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses increased by 403% to X tons, rising for the second consecutive year after three years of decline. Over the period under review, exports showed a significant increase. The pace of growth was the most pronounced in 2017 when exports increased by 748%. The volume of export peaked in 2022 and is expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Overall, exports posted a resilient increase. The most prominent rate of growth was recorded in 2021 when exports increased by 101% against the previous year. Over the period under review, the exports attained the maximum in 2022 and are expected to retain growth in years to come.

Exports by Country

South Africa prevails in exports structure, amounting to X tons, which was approx. 96% of total exports in 2022. Morocco (X tons) followed a long way behind the leaders.

South Africa was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of +38.5% from 2012 to 2022. At the same time, Morocco (+11.0%) displayed positive paces of growth. South Africa (+22 p.p.) significantly strengthened its position in terms of the total exports, while Morocco saw its share reduced by -17.4% from 2012 to 2022, respectively.

In value terms, the largest prophylactic medicaments containing insulin supplying countries in Africa were South Africa ($X) and Morocco ($X).

Among the main exporting countries, South Africa, with a CAGR of +18.8%, saw the highest rates of growth with regard to the value of exports, over the period under review.

Export Prices by Country

In 2022, the export price in Africa amounted to $X per ton, reducing by -62.8% against the previous year. Over the period under review, the export price showed a deep downturn. The pace of growth appeared the most rapid in 2019 an increase of 111%. The level of export peaked at $X per ton in 2014; however, from 2015 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Morocco ($X per ton), while South Africa totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Morocco (-4.8%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Africa

For the fourth year in a row, Africa recorded growth in supplies from abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 8% to X tons in 2022. Total imports indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of +5.7% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +65.7% against 2018 indices. The pace of growth appeared the most rapid in 2019 when imports increased by 28%. Over the period under review, imports hit record highs in 2022 and are likely to continue growth in years to come.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2022. Total imports indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of +5.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +82.2% against 2018 indices. The most prominent rate of growth was recorded in 2019 with an increase of 61%. Over the period under review, imports hit record highs at $X in 2021, and then fell in the following year.

Imports by Country

Algeria was the main importing country with an import of about X tons, which recorded 41% of total imports. South Africa (X tons) held an 18% share (based on physical terms) of total imports, which put it in second place, followed by Tunisia (9.5%), Morocco (7.2%) and Sudan (6.3%). Libya (X tons) and Cote d'Ivoire (X tons) held a minor share of total imports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into Algeria stood at +5.7%. At the same time, Libya (+44.1%), Sudan (+34.2%), Cote d'Ivoire (+28.8%), Tunisia (+23.1%) and Morocco (+8.5%) displayed positive paces of growth. Moreover, Libya emerged as the fastest-growing importer imported in Africa, with a CAGR of +44.1% from 2012-2022. South Africa experienced a relatively flat trend pattern. While the share of Tunisia (+7.5 p.p.), Sudan (+5.7 p.p.), Libya (+2.4 p.p.), Cote d'Ivoire (+1.8 p.p.) and Morocco (+1.7 p.p.) increased significantly in terms of the total imports from 2012-2022, the share of South Africa (-13.5 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Algeria ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Africa, comprising 66% of total imports. The second position in the ranking was taken by South Africa ($X), with a 9.4% share of total imports. It was followed by Tunisia, with a 7.2% share.

In Algeria, prophylactic medicaments containing insulin imports increased at an average annual rate of +6.1% over the period from 2012-2022. In the other countries, the average annual rates were as follows: South Africa (-2.3% per year) and Tunisia (+14.3% per year).

Import Prices by Country

In 2022, the import price in Africa amounted to $X per ton, falling by -14.8% against the previous year. Overall, the import price recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2019 when the import price increased by 25%. The level of import peaked at $X per ton in 2021, and then dropped in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Algeria ($X per ton), while Sudan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Cote d'Ivoire (+2.1%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :